Tuberous Sclerosis:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Tuberous Sclerosis Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tuberous Sclerosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Tuberous Sclerosis Therapeutics Clinical Trials 24
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Novartis Pharmaceuticals Corporation 26
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Clinical Trial Overview of Top Institutes / Government 28
Cincinnati Children’s Hospital Medical Center 28
Clinical Trial Overview of Cincinnati Children’s Hospital Medical Center 28
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Cardiff University 30
Clinical Trial Overview of Cardiff University 30
Boston Children’s Hospital 31
Clinical Trial Overview of Boston Children’s Hospital 31
The University of Texas Health Science Center at Houston 32
Clinical Trial Overview of The University of Texas Health Science Center at Houston 32
Erasmus MC 33
Clinical Trial Overview of Erasmus MC 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
The University of Nottingham 35
Clinical Trial Overview of The University of Nottingham 35
Fundacio Puigvert 36
Clinical Trial Overview of Fundacio Puigvert 36
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 37
Clinical Trial Overview of Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 37
YAMAGUCHI UNIVERSITY 38
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 38
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 39
Clinical Trial Overview of Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 39
University Hospitals Bristol NHS Trust 40
Clinical Trial Overview of University Hospitals Bristol NHS Trust 40
Le Bonheur Children’s Medical Center 41
Clinical Trial Overview of Le Bonheur Children’s Medical Center 41
Children’s Hospital Medical Center of Akron 42
Clinical Trial Overview of Children’s Hospital Medical Center of Akron 42
Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Five Key Clinical Profiles 44
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81


【レポート販売概要】

■ タイトル:Tuberous Sclerosis:グローバル臨床試験レビューH2, 2013
■ 英文:Tuberous Sclerosis Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162304
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。